Back
Innovent Biologics Stock Price Chart
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Buy
62
IVBXF
Innovent Biologics
Last Price:
$5.94
Seasonality Move:
19.23%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bearish and IVBXF is experiencing slight buying pressure.
Innovent Biologics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.76 | Sell |
| 20-day SMA: | 6.35 | Sell |
| 50-day SMA: | 5.78 | Buy |
| 200-day SMA: | 5.22 | Buy |
| 8-day EMA: | 6.57 | Sell |
| 20-day EMA: | 6.35 | Sell |
| 50-day EMA: | 5.88 | Buy |
| 200-day EMA: | 5.27 | Buy |
Innovent Biologics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 42.98 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.5 - 6.72) | Sell |
| Bollinger Bands (100): | (4.36 - 5.96) | Buy |
Innovent Biologics Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Innovent Biologics Stock
Is Innovent Biologics Stock a Buy?
-
Innovent Biologics share price is 5.94 while IVBXF 8-day simple moving average is 6.76, which is a Sell signal.
-
The stock price of IVBXF is 5.94 while Innovent Biologics 20-day SMA is 6.35, which makes it a Sell.
-
Innovent Biologics 50-day simple moving average is 5.78 while IVBXF share price is 5.94, making it a Buy technically.
-
IVBXF stock price is 5.94 and Innovent Biologics 200-day simple moving average is 5.22, creating a Buy signal.
IVBXF Technical Analysis vs Fundamental Analysis
Buy
62
Innovent Biologics (IVBXF)
is a Buy
Is Innovent Biologics a Buy or a Sell?
-
Innovent Biologics stock is rated a BuyThe current Innovent Biologics [IVBXF] share price is $5.94. The Score for IVBXF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Innovent Biologics Stock Info
Market Cap:
9.7B
Price in USD:
5.94
Share Volume:
500
Innovent Biologics 52-Week Range
52-Week High:
6.88
52-Week Low:
3.91
Buy
62
Innovent Biologics (IVBXF)
is a Buy
Innovent Biologics Share Price Forecast
-
What is the Innovent Biologics stock price today?The Innovent Biologics stock price is 5.94 USD today.
-
Will IVBXF stock go up or go down?Innovent Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is Innovent Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innovent Biologics is not overvalued.
Is Innovent Biologics Stock a Buy?
-
Innovent Biologics share price is 5.94 while IVBXF 8-day exponential moving average is 6.57, which is a Sell signal.
-
The stock price of IVBXF is 5.94 while Innovent Biologics 20-day EMA is 6.35, which makes it a Sell.
-
Innovent Biologics 50-day exponential moving average is 5.88 while IVBXF share price is 5.94, making it a Buy technically.
-
IVBXF stock price is 5.94 and Innovent Biologics 200-day simple moving average is 5.27, creating a Buy signal.
Technical Analysis of Innovent Biologics
Should I short Innovent Biologics stock?
-
IVBXF Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Innovent Biologics is a Buy
-
Innovent Biologics Relative Strength Index (RSI) is 42.98, which suggest Innovent Biologics is oversold
-
The Bollinger Bands (25) for Innovent Biologics is (5.5 - 6.72), which suggest Innovent Biologics is a Buy
-
The Bollinger Bands (100) for Innovent Biologics is (4.36 - 5.96), which suggest Innovent Biologics is a Buy
* Innovent Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.